These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 3546779)
21. Acute and chronic effects of diltiazem on A-V conduction at rest and during exercise. Ritterman JB; Hossack KF; Bruce RA J Electrocardiol; 1982 Jan; 15(1):41-6. PubMed ID: 7040581 [TBL] [Abstract][Full Text] [Related]
22. Verapamil therapy: a new approach to pharmacologic treatment of hypertrophic cardiomyopathy. Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE Chest; 1980 Jul; 78(1 Suppl):239-47. PubMed ID: 6995039 [TBL] [Abstract][Full Text] [Related]
23. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy]. Crittin J; Mayor C; Bloch A Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537 [TBL] [Abstract][Full Text] [Related]
24. Diastolic function in hypertrophic cardiomyopathy: effects of propranolol and verapamil on diastolic stiffness. Hess OM; Grimm J; Krayenbuehl HP Eur Heart J; 1983 Nov; 4 Suppl F():47-56. PubMed ID: 6686544 [TBL] [Abstract][Full Text] [Related]
25. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE Clin Invest Med; 1980; 3(1-2):195-203. PubMed ID: 7009000 [No Abstract] [Full Text] [Related]
26. Efficacy of diltiazem in angina on effort: a multicenter trial. Hossack KF; Pool PE; Steele P; Crawford MH; DeMaria AN; Cohen LS; Ports TA Am J Cardiol; 1982 Feb; 49(3):567-72. PubMed ID: 7036710 [TBL] [Abstract][Full Text] [Related]
27. Treatment of hypertrophic cardiomyopathy: relation to pathological mechanisms. Kaltenbach M; Hopf R J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():59-68. PubMed ID: 4040978 [TBL] [Abstract][Full Text] [Related]
28. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. Rosing DR; Kent KM; Maron BJ; Epstein SE Circulation; 1979 Dec; 60(6):1208-13. PubMed ID: 574067 [No Abstract] [Full Text] [Related]
30. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Bonow RO; Dilsizian V; Rosing DR; Maron BJ; Bacharach SL; Green MV Circulation; 1985 Oct; 72(4):853-64. PubMed ID: 4040821 [TBL] [Abstract][Full Text] [Related]
31. Hypertrophic cardiomyopathy in pediatric patients: effect of verapamil on regional and global left ventricular diastolic function. Pacileo G; De Cristofaro M; Russo MG; Sarubbi B; Pisacane C; Calabrò R Can J Cardiol; 2000 Feb; 16(2):146-52. PubMed ID: 10694584 [TBL] [Abstract][Full Text] [Related]
32. The acute response of left ventricular filling dynamics to intravenous verapamil predicts the changes in exercise tolerance after oral verapamil therapy in patients with hypertrophic cardiomyopathy. Tendera M; Schneeweiss A; Bartoszewski A; Polonski L; Wodniecki J; Salamon A Eur Heart J; 1993 Mar; 14(3):410-5. PubMed ID: 8458363 [TBL] [Abstract][Full Text] [Related]
33. Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood flow. Fugit MD; Rubal BJ; Donovan DJ J Invasive Cardiol; 2000 Feb; 12(2):80-5. PubMed ID: 10731269 [TBL] [Abstract][Full Text] [Related]
34. Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension. Frishman WH; Charlap S; Goldberger J; Kimmel B; Stroh J; Dorsa F; Allen L; Strom J Am J Cardiol; 1985 Dec; 56(16):41H-46H. PubMed ID: 3934948 [TBL] [Abstract][Full Text] [Related]
35. Improved exercise performance in persons with stable angina pectoris receiving diltiazem. Hossack KF; Bruce RA Am J Cardiol; 1981 Jan; 47(1):95-101. PubMed ID: 7457415 [TBL] [Abstract][Full Text] [Related]
36. [Comparative evaluation of 3 calcium antagonist drugs in patients with stable angina of effort. Double-blind placebo-controlled randomized study]. Fazzini PF; Pucci PD; Santoro GM; Buonamici P; Buzzigoli A; Sarro F G Ital Cardiol; 1987 Mar; 17(3):239-45. PubMed ID: 3301505 [TBL] [Abstract][Full Text] [Related]
37. [Effects of verapamil on the left ventricular diastolic function and diastolic asynchrony in patients with hypertrophic cardiomyopathy]. Emoto R; Yokota Y; Miki T; Usuki S; Miki T; Nomura H; Takeuchi Y; Nakatani M; Fukuzaki H J Cardiol; 1991; 21(1):87-96. PubMed ID: 1817184 [TBL] [Abstract][Full Text] [Related]
39. Effects of diltiazem on myocardial perfusion abnormalities during exercise in patients with hypertrophic cardiomyopathy. Sugihara H; Taniguchi Y; Ito K; Terada K; Matsumoto K; Kinoshita N; Azuma A; Ushijima Y; Maeda T; Nakagawa M Ann Nucl Med; 1998 Dec; 12(6):349-54. PubMed ID: 9972372 [TBL] [Abstract][Full Text] [Related]
40. Effects of verapamil on left ventricular diastolic filling in children with hypertrophic cardiomyopathy. Shaffer EM; Rocchini AP; Spicer RL; Juni J; Snider R; Crowley DC; Rosenthal A Am J Cardiol; 1988 Feb; 61(6):413-7. PubMed ID: 3341224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]